Comparative effects of glycine and d-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis

This publication has 21 references indexed in Scilit:

• Placebo-Controlled Trial of d-Cycloserine Added to Conventional Neuroleptics, Olanzapine, or Risperidone in Schizophrenia
  American Journal of Psychiatry, 2002
• Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors
  Biological Psychiatry, 1999
• Double-blind, placebo-controlled, crossover trial of D-cycloserine adjuvant therapy for treatment-resistant schizophrenia
  International Journal of Neuropsychopharmacology, 1998
• Glycine and D-serine decrease MK-801-induced hyperactivity in mice
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1997
• Efficacy and tolerance of D-cycloserine in drug-free schizophrenic patients
  Biological Psychiatry, 1996
• Double-Blind, Placebo-Controlled, Crossover Trial of Glycine Adjuvant Therapy for Treatment-Resistant Schizophrenia
  The British Journal of Psychiatry, 1996
• D-Cycloserine Adjuvant Therapy to Molindone in the Treatment of Schizophrenia
  Clinical Neuropharmacology, 1996
• Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial
  Biological Psychiatry, 1996
• d-Cycloserine: A ligand for the coupled glycine receptor has partial agonist characteristics
  Neuroscience Letters, 1989
• Glycine potentiates the NMDA response in cultured mouse brain neurons
  Nature, 1987